Laurus Labs Limited - Asset Resilience Ratio

Latest as of September 2025: 0.74%

Laurus Labs Limited (LAURUSLABS) has an Asset Resilience Ratio of 0.74% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read LAURUSLABS total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Rs697.20 Million
≈ $7.54 Million USD Cash + Short-term Investments

Total Assets

Rs94.15 Billion
≈ $1.02 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2015–2025)

This chart shows how Laurus Labs Limited's Asset Resilience Ratio has changed over time. See Laurus Labs Limited (LAURUSLABS) shareholders funds for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Laurus Labs Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see LAURUSLABS market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Rs633.80 Million 0.67%
Short-term Investments Rs63.40 Million 0.07%
Total Liquid Assets Rs697.20 Million 0.74%

Asset Resilience Insights

  • Limited Liquidity: Laurus Labs Limited maintains only 0.74% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Laurus Labs Limited Industry Peers by Asset Resilience Ratio

Compare Laurus Labs Limited's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 3.73%
Yuhan Corp.
KO:000100
Drug Manufacturers - Specialty & Generic 0.99%
Tasly Pharmaceutical Group Co Ltd
SHG:600535
Drug Manufacturers - Specialty & Generic 9.09%
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267
Drug Manufacturers - Specialty & Generic 0.02%
Zhejiang Jiuzhou Pharm Co Ltd
SHG:603456
Drug Manufacturers - Specialty & Generic 0.01%
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
Drug Manufacturers - Specialty & Generic 26.36%
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
Drug Manufacturers - Specialty & Generic 0.29%
Cronos Group Inc
TO:CRON
Drug Manufacturers - Specialty & Generic 69.94%

Annual Asset Resilience Ratio for Laurus Labs Limited (2015–2025)

The table below shows the annual Asset Resilience Ratio data for Laurus Labs Limited.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-03-31 0.57% Rs528.20 Million
≈ $5.71 Million
Rs93.36 Billion
≈ $1.01 Billion
+0.33pp
2024-03-31 0.23% Rs195.50 Million
≈ $2.11 Million
Rs83.87 Billion
≈ $907.03 Million
-0.15pp
2023-03-31 0.38% Rs294.00 Million
≈ $3.18 Million
Rs76.60 Billion
≈ $828.44 Million
+0.06pp
2022-03-31 0.32% Rs222.40 Million
≈ $2.41 Million
Rs69.68 Billion
≈ $753.57 Million
-0.36pp
2021-03-31 0.68% Rs390.70 Million
≈ $4.23 Million
Rs57.51 Billion
≈ $621.92 Million
+0.68pp
2020-03-31 0.00% Rs880.00K
≈ $9.52K
Rs37.50 Billion
≈ $405.58 Million
+0.00pp
2019-03-31 0.00% Rs740.00K
≈ $8.00K
Rs33.31 Billion
≈ $360.26 Million
+2.21pp
2018-03-31 -2.20% Rs-664.70 Million
≈ $-7.19 Million
Rs30.17 Billion
≈ $326.25 Million
+0.24pp
2017-03-31 -2.44% Rs-648.62 Million
≈ $-7.01 Million
Rs26.53 Billion
≈ $286.96 Million
-2.09pp
2016-03-31 -0.35% Rs-81.68 Million
≈ $-883.34K
Rs23.03 Billion
≈ $249.07 Million
+3.48pp
2015-03-31 -3.84% Rs-706.89 Million
≈ $-7.64 Million
Rs18.43 Billion
≈ $199.28 Million
--
pp = percentage points

About Laurus Labs Limited

NSE:LAURUSLABS India Drug Manufacturers - Specialty & Generic
Market Cap
$6.43 Billion
Rs594.36 Billion INR
Market Cap Rank
#3039 Global
#136 in India
Share Price
Rs1100.95
Change (1 day)
-0.47%
52-Week Range
Rs586.75 - Rs1135.75
All Time High
Rs1135.75
About

Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It… Read more